# Lilly (Eli) > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:ed5c886b-f007-4eec-951c-0141de4aae25 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/eli-lilly-co | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 59 | | Claims under review | 1 | | Evidence records | 31 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T04:45:02.848559+00:00 | | Last reviewed | 2026-10-16T04:45:02.848559+00:00 | ## Identity - Legal name: ELI LILLY & Co - Display name: Lilly (Eli) ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T07:44:32.295377+00:00 | | Completeness | 0.455 | | Record Quality | 0.798 | | Directors | 13 | | Committees | 12 | | Governance events | 30 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | PUBLISHED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Carolyn R. Bertozzi, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:11 - David Ricks: Chair. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:10 - Gabrielle Sulzberger: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. Committees: Audit (member); Audit; Directors and Corporate Governance (member); Directors and Corporate Governance (member). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:12 - J. Erik Fyrwald: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. Committees: Science and Technology (member); Talent and Compensation (member); Talent and Compensation; Science and Technology (member). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:13 - Jamere Jackson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. Committees: Audit (chair); Audit · Chair; Directors and Corporate Governance (member); Directors and Corporate Governance (member). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:14 - Jon Moeller: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. Committees: Audit (member); Audit; Directors and Corporate Governance (member); Directors and Corporate Governance (member). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:15 - Juan R. Luciano: Lead Independent Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. Committees: Directors and Corporate Governance (chair); Directors and Corporate Governance · Chair; Talent and Compensation (member); Talent and Compensation (member). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:16 - Katherine Baicker, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:17 - Kimberly Johnson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. Committees: Ethics and Compliance (member); Talent and Compensation (member); Talent and Compensation; Ethics and Compliance (member). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:18 - Mary Lynne Hedley, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:19 - Ralph Alvarez: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. Committees: Audit (member); Audit; Talent and Compensation · Chair (member); Talent and Compensation (chair). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:20 - William G. Kaelin Jr., M.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:21 - William Kaelin, Jr.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2012-01-01. Committees: Directors and Corporate Governance (member); Directors and Corporate Governance; Science and Technology · Chair (member); Science and Technology (chair). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:22 ## Committees - Audit (audit). Chair: Jamere Jackson. Members: Jamere Jackson (chair, current); Gabrielle Sulzberger (member, current); Jon Moeller (member, current); Ralph Alvarez (member, current). committee_id=alpha:committee:eli-lilly-co:audit - Audit · Chair; Directors and Corporate Governance (audit). Chair: NOT_PUBLISHED. Members: Jamere Jackson (member, current). committee_id=alpha:committee:eli-lilly-co:audit-chair-directors-and-corporate-governance - Audit; Directors and Corporate Governance (audit). Chair: NOT_PUBLISHED. Members: Gabrielle Sulzberger (member, current); Jon Moeller (member, current). committee_id=alpha:committee:eli-lilly-co:audit-directors-and-corporate-governance - Audit; Talent and Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Ralph Alvarez (member, current). committee_id=alpha:committee:eli-lilly-co:audit-talent-and-compensation-chair - Directors and Corporate Governance (nominating_governance). Chair: Juan R. Luciano. Members: Juan R. Luciano (chair, current); Gabrielle Sulzberger (member, current); Jamere Jackson (member, current); Jon Moeller (member, current); William Kaelin, Jr. (member, current). committee_id=alpha:committee:eli-lilly-co:directors-and-corporate-governance - Directors and Corporate Governance · Chair; Talent and Compensation (compensation). Chair: NOT_PUBLISHED. Members: Juan R. Luciano (member, current). committee_id=alpha:committee:eli-lilly-co:directors-and-corporate-governance-chair-talent-and-compensation - Directors and Corporate Governance; Science and Technology · Chair (nominating_governance). Chair: NOT_PUBLISHED. Members: William Kaelin, Jr. (member, current). committee_id=alpha:committee:eli-lilly-co:directors-and-corporate-governance-science-and-technology-chair - Ethics and Compliance (other). Chair: NOT_PUBLISHED. Members: Kimberly Johnson (member, current). committee_id=alpha:committee:eli-lilly-co:ethics-and-compliance - Science and Technology (technology). Chair: William Kaelin, Jr.. Members: William Kaelin, Jr. (chair, current); J. Erik Fyrwald (member, current). committee_id=alpha:committee:eli-lilly-co:science-and-technology - Talent and Compensation (compensation). Chair: Ralph Alvarez. Members: Ralph Alvarez (chair, current); J. Erik Fyrwald (member, current); Juan R. Luciano (member, current); Kimberly Johnson (member, current). committee_id=alpha:committee:eli-lilly-co:talent-and-compensation - Talent and Compensation; Ethics and Compliance (compensation). Chair: NOT_PUBLISHED. Members: Kimberly Johnson (member, current). committee_id=alpha:committee:eli-lilly-co:talent-and-compensation-ethics-and-compliance - Talent and Compensation; Science and Technology (compensation). Chair: NOT_PUBLISHED. Members: J. Erik Fyrwald (member, current). committee_id=alpha:committee:eli-lilly-co:talent-and-compensation-science-and-technology ## Executive leadership - Adrienne Brown: Executive Vice President and President, Lilly Immunology [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:23 - Anat Hakim: Executive Vice President, General Counsel and Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:24 - Carole Ho: Executive Vice President and President, Lilly Neuroscience [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:25 - Daniel Skovronsky: Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Laboratories [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:26 - David Ricks: Chair, President, and Chief Executive Officer (CEO) [CEO]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:27 - Diogo Rau: Executive Vice President and Chief Information and Digital Officer. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:28 - Edgardo Hernandez: Executive Vice President and President, Manufacturing Operations [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:29 - Eric Dozier: Executive Vice President, Chief People Officer [CHRO]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:30 - Ilya Yuffa: Executive Vice President and President, Lilly USA and Global Customer Capabilities [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:31 - Jacob Van Naarden: Executive Vice President, President, Lilly Oncology and Head of Corporate Business Development [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:32 - Kenneth Custer: Executive Vice President and President, Lilly Cardiometabolic Health [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:33 - Lucas Montarce: Executive Vice President and Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:34 - Melissa Seymour: Executive Vice President, Global Quality. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:35 - Patrik Jonsson: Executive Vice President and President, Lilly International [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:36 ## Governance events - DIRECTOR_APPOINTED: Carolyn R. Bertozzi, Ph.D. seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:17hlkig18tmdxc - DIRECTOR_APPOINTED: Gabrielle Sulzberger seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1bw06071fuvq6n - DIRECTOR_APPOINTED: J. Erik Fyrwald seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:y1kr4d9m7f7v - DIRECTOR_APPOINTED: Jamere Jackson seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:ti0r3d1bl0k7n - DIRECTOR_APPOINTED: Juan R. Luciano seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1qwesnj171hclb - LEAD_DIRECTOR_CHANGED: Juan R. Luciano lead independent director of Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:zo8jyr1w9pxwv - DIRECTOR_APPOINTED: Katherine Baicker, Ph.D. seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:c9vz9ex6llpy - DIRECTOR_APPOINTED: Kimberly Johnson seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:19raehk1w16kk2 - DIRECTOR_APPOINTED: Mary Lynne Hedley, Ph.D. seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1kq8gmo1c33cdm - DIRECTOR_APPOINTED: Ralph Alvarez seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1mgq4s21o8zt0q - DIRECTOR_APPOINTED: William G. Kaelin Jr., M.D. seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1c17zcb12o68m7 - COMMITTEE_CREATED: Audit · Chair; Directors and Corporate Governance committee of Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:l2smndb3k837 - COMMITTEE_MEMBER_ADDED: Jamere Jackson member of Audit · Chair; Directors and Corporate Governance, effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:100l0d5czo25z - COMMITTEE_CREATED: Audit; Directors and Corporate Governance committee of Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1xaqkub1q8m1yx - COMMITTEE_MEMBER_ADDED: Gabrielle Sulzberger member of Audit; Directors and Corporate Governance, effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1ungq3kxzsxj - COMMITTEE_CREATED: Audit; Talent and Compensation · Chair committee of Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:44kk1u18dp5mi - COMMITTEE_MEMBER_ADDED: Ralph Alvarez member of Audit; Talent and Compensation · Chair, effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:164mj6rbxb4jz - COMMITTEE_CREATED: Directors and Corporate Governance · Chair; Talent and Compensation committee of Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1opxmd71c050tz - COMMITTEE_MEMBER_ADDED: Juan R. Luciano member of Directors and Corporate Governance · Chair; Talent and Compensation, effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:lez34z1frfbzr - COMMITTEE_CREATED: Talent and Compensation; Ethics and Compliance committee of Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1b0kgia7qnipq - COMMITTEE_MEMBER_ADDED: Kimberly Johnson member of Talent and Compensation; Ethics and Compliance, effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1182zjqmqdaaw - COMMITTEE_CREATED: Talent and Compensation; Science and Technology committee of Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:13de6651gjmak3 - COMMITTEE_MEMBER_ADDED: J. Erik Fyrwald member of Talent and Compensation; Science and Technology, effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:11tnuwq1eo0z82 - DIRECTOR_APPOINTED: Jon Moeller seat on Lilly (Eli), effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1bex4ir13yswm1 - COMMITTEE_MEMBER_ADDED: Jon Moeller member of Audit; Directors and Corporate Governance, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1h2bfv1k2bn2l - DIRECTOR_APPOINTED: David Ricks seat on Lilly (Eli), effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:63rzx2gn9kpq - BOARD_CHAIR_CHANGED: David Ricks chairs board Lilly (Eli), effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:sls4961rqqnx2 - DIRECTOR_APPOINTED: William Kaelin, Jr. seat on Lilly (Eli), effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1cimw8wvmfjt6 - COMMITTEE_CREATED: Directors and Corporate Governance; Science and Technology · Chair committee of Lilly (Eli), effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:192kyaemkzjp2 - COMMITTEE_MEMBER_ADDED: William Kaelin, Jr. member of Directors and Corporate Governance; Science and Technology · Chair, effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:y4atc0ubqjd6 ## Scoped resources - `alpha://company/eli-lilly-co` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record - `alpha://company/eli-lilly-co/identity` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=identity - `alpha://company/eli-lilly-co/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=corporate-structure - `alpha://company/eli-lilly-co/board` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=board - `alpha://company/eli-lilly-co/committees` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=committees - `alpha://company/eli-lilly-co/leadership` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=leadership - `alpha://company/eli-lilly-co/ownership` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=ownership - `alpha://company/eli-lilly-co/financials` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=financials - `alpha://company/eli-lilly-co/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=capital-structure - `alpha://company/eli-lilly-co/compensation` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=compensation - `alpha://company/eli-lilly-co/governance` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=governance - `alpha://company/eli-lilly-co/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=shareholder-governance - `alpha://company/eli-lilly-co/audit` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=audit - `alpha://company/eli-lilly-co/legal` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=legal - `alpha://company/eli-lilly-co/risk` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=risk - `alpha://company/eli-lilly-co/cyber` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=cyber - `alpha://company/eli-lilly-co/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=ai-governance - `alpha://company/eli-lilly-co/agents` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=agents - `alpha://company/eli-lilly-co/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=ecosystem - `alpha://company/eli-lilly-co/events` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=events - `alpha://company/eli-lilly-co/relationships` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=relationships - `alpha://company/eli-lilly-co/assessments` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=assessments - `alpha://company/eli-lilly-co/evidence` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:38: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:jamere-jackson","name":"Jamere Jackson"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:39: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:gabrielle-sulzberger","name":"Gabrielle Sulzberger"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:40: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jon-moeller","name":"Jon Moeller"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:41: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:ralph-alvarez","name":"Ralph Alvarez"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:43: `{"kind":"committee_appointment","original_name":"Directors and Corporate Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:juan-r-luciano","name":"Juan R. Luciano"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:44: `{"kind":"committee_appointment","original_name":"Directors and Corporate Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:gabrielle-sulzberger","name":"Gabrielle Sulzberger"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:45: `{"kind":"committee_appointment","original_name":"Directors and Corporate Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:jamere-jackson","name":"Jamere Jackson"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:46: `{"kind":"committee_appointment","original_name":"Directors and Corporate Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:jon-moeller","name":"Jon Moeller"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:47: `{"kind":"committee_appointment","original_name":"Directors and Corporate Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:william-kaelin-jr","name":"William Kaelin, Jr."},"source_id":"board_seats"}` - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:49: `{"kind":"committee_appointment","original_name":"Ethics and Compliance","category":"other","role":"member","person":{"alpha_id":"alpha:person:kimberly-johnson","name":"Kimberly Johnson"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:51: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"chair","person":{"alpha_id":"alpha:person:william-kaelin-jr","name":"William Kaelin, Jr."},"source_id":"board_seats"}` - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:52: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"member","person":{"alpha_id":"alpha:person:j-erik-fyrwald","name":"J. Erik Fyrwald"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:54: `{"kind":"committee_appointment","original_name":"Talent and Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:ralph-alvarez","name":"Ralph Alvarez"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:55: `{"kind":"committee_appointment","original_name":"Talent and Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:j-erik-fyrwald","name":"J. Erik Fyrwald"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:56: `{"kind":"committee_appointment","original_name":"Talent and Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:juan-r-luciano","name":"Juan R. Luciano"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:57: `{"kind":"committee_appointment","original_name":"Talent and Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:kimberly-johnson","name":"Kimberly Johnson"},"source_id":"board_seats"}` ## Leadership - David Ricks: Chair. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:10. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dbd763f05a328231373a04f53cb7e34b0c1f2f6ff7b1d1446e22655cde0bea13. - Carolyn R. Bertozzi, Ph.D.: Director. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:11. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:afdcf1522906ff7cd99650671d36a788c0a2bbc2384bc2e7ad892a5c96666ca3. - Gabrielle Sulzberger: Director, Audit; Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:12. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e6f35099c1291158a9addc4a0a50e2118b08e3fe1ca78f72723bb1a6d5a1a541. - J. Erik Fyrwald: Director, Talent and Compensation; Science and Technology. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:13. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ce0ed99cf945cc8b381a90ec2e8c56de1f453e44d6725685938cfc26a2340234. - Jamere Jackson: Director, Audit · Chair; Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:14. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ff0b6d4eb95617660a96b052ea5b31ff4bf77acd4b885a5bdd7b69929c322267. - Jon Moeller: Director, Audit; Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:15. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2d93a47596e17644c4bcea5aad8b625bba64903d0edc6b61dbfa0068bea2f7ac. - Juan R. Luciano: Lead Independent Director, Directors and Corporate Governance · Chair; Talent and Compensation. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:16. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b459027c37cb8a9013662e0b07e857425a717e7a5b11f3bf5b6624cc9ced92ce. - Katherine Baicker, Ph.D.: Director. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:17. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f6326cbfa637699b5f7848e437804a64fd3cdc34df2c96b5f2d63de0f48345f1. - Kimberly Johnson: Director, Talent and Compensation; Ethics and Compliance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:18. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4a30c098a4a68e57eafaf7740a5eea207dee07f5a712687bb73d3957f6e80584. - Mary Lynne Hedley, Ph.D.: Director. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:19. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c725f196ab40e8dfeaee09d14e12e788792f57b370209581b9e86f3b9ed80f75. - Ralph Alvarez: Director, Audit; Talent and Compensation · Chair. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:20. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6ec4b33661a2eef359a5176343bdbc7a2d4a12e807fca67b8c0e2a9bf34df44c. - William G. Kaelin Jr., M.D.: Director. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:21. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:314fcb01d93646e1b1470c75eae79bb8f212dd4f354c1f72f50efcaa38b10ce8. - William Kaelin, Jr.: Director, Directors and Corporate Governance; Science and Technology · Chair. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:22. Valid from: 2012-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cffbb81b357bbe1614740a5ab14d015520e27f8590c7e92e5432b2a0c157f1d0. - Adrienne Brown: Executive Vice President and President, Lilly Immunology. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:334b0745cf84f53aa5f5d0fda5cba627b952c82477b730c40c7ec94e7bcd4531. - Anat Hakim: Executive Vice President, General Counsel and Secretary. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:343df0b317f9d1e9978e9c350f18fdcabb40abb4a1f3f292c009e9d056e117e8. - Carole Ho: Executive Vice President and President, Lilly Neuroscience. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ad62fa3d97af3c6c29f92650b3bf17c9b48f101547bef29f1c7202d5c666d08a. - Daniel Skovronsky: Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Laboratories. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:299846c67451289b7468682bbf6e2271eca789ba4299cff991517fed7bff1a85. - David Ricks: Chair, President, and Chief Executive Officer (CEO). Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:571a3ae2a24c839ce4b2614fd38c75681b66eea7a926baa05d9cc5db6fe2d493. - Diogo Rau: Executive Vice President and Chief Information and Digital Officer. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dbbcca4ee29ed0233d90717206029da707483f3a5cca82b43f01a20819f85751. - Edgardo Hernandez: Executive Vice President and President, Manufacturing Operations. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c6bcf221e6c5cbef2ceb6c5c67bcafb23b4731dd21078a0614aae3ef80c18a8f. - Eric Dozier: Executive Vice President, Chief People Officer. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0a31559e6fb655f082d3a87eec283e445815c879196b5283e6d208117d028701. - Ilya Yuffa: Executive Vice President and President, Lilly USA and Global Customer Capabilities. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e269a8ea551874e338daad716989e73eb0cbc77af878c4f3736367df6c01275d. - Jacob Van Naarden: Executive Vice President, President, Lilly Oncology and Head of Corporate Business Development. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:55506d0bdb37d7ce7e46f5ffcaa79265a53b486bc4c3d7328df99ae54cd84a24. - Kenneth Custer: Executive Vice President and President, Lilly Cardiometabolic Health. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02ae298c8e40d956c1c847839ceae7474cb8695ee35cf0f9ac23f9947e1ba5e9. - Lucas Montarce: Executive Vice President and Chief Financial Officer. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:21a7ae2723c0aaf715aa0ad7c4393ff9d301fbcbddbe659020e438240086a473. - Melissa Seymour: Executive Vice President, Global Quality. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2c25184b065c1e34928156525bde08ae0108daa40dc0ef6144d183197f7cac39. - Patrik Jonsson: Executive Vice President and President, Lilly International. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:36. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fef8c0c6217d0f2edc9141992ee09c46be42c3fb8dcfb525755c9a67e9302d6d. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Jamere Jackson; Members Jamere Jackson (Chair); Gabrielle Sulzberger; Jon Moeller; Ralph Alvarez. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_record:37. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - Directors and Corporate Governance: Chair Juan R. Luciano; Members Juan R. Luciano (Chair); Gabrielle Sulzberger; Jamere Jackson; Jon Moeller; William Kaelin, Jr.. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_record:42. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - Ethics and Compliance: Chair not stated; Members Kimberly Johnson. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_record:48. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - Science and Technology: Chair William Kaelin, Jr.; Members William Kaelin, Jr. (Chair); J. Erik Fyrwald. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_record:50. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - Talent and Compensation: Chair Ralph Alvarez; Members Ralph Alvarez (Chair); J. Erik Fyrwald; Juan R. Luciano; Kimberly Johnson. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_record:53. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - S&P 500 (SPX). Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:index_membership:58. Valid from: 1970-12-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a. ## Legal Name - ELI LILLY & Co. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11. ## Entity Status - Public listing published. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11. ## Official Website - https://www.lilly.com. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:official_website:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e35bbf6e0ccb75ab8426bc334cf18605a3a87350df5637af4b29dc23bcd83c10. ## Published Fact - US. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11. - IN. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11. - Healthcare. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:published_fact:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11. - Drug Manufacturers. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:published_fact:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11. - https://www.lilly.com. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:published_fact:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e35bbf6e0ccb75ab8426bc334cf18605a3a87350df5637af4b29dc23bcd83c10. ## Committee Appointment - Jamere Jackson: chair, Audit. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:38. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - Gabrielle Sulzberger: member, Audit. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:39. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - Jon Moeller: member, Audit. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:40. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - Ralph Alvarez: member, Audit. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:41. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - Juan R. Luciano: chair, Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:43. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - Gabrielle Sulzberger: member, Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:44. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - Jamere Jackson: member, Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:45. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - Jon Moeller: member, Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:46. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - William Kaelin, Jr.: member, Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:47. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - Kimberly Johnson: member, Ethics and Compliance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:49. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - William Kaelin, Jr.: chair, Science and Technology. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:51. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - J. Erik Fyrwald: member, Science and Technology. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:52. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - Ralph Alvarez: chair, Talent and Compensation. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:54. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - J. Erik Fyrwald: member, Talent and Compensation. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:55. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - Juan R. Luciano: member, Talent and Compensation. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:56. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. - Kimberly Johnson: member, Talent and Compensation. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:57. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378. ## Security Listing - LLY (NYSE). Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:security_listing:59. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11. - LLY (SIX). Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:security_listing:60. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/eli-lilly-co). - alpha:projection-evidence:e35bbf6e0ccb75ab8426bc334cf18605a3a87350df5637af4b29dc23bcd83c10: [ELI LILLY & Co Form 10-K (filed 2026-02-12)](https://www.sec.gov/Archives/edgar/data/59478/000005947826000013/lly-20251231.htm). - alpha:projection-evidence:document:dbd763f05a328231373a04f53cb7e34b0c1f2f6ff7b1d1446e22655cde0bea13: [Eli Lilly director board source](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:projection-evidence:document:afdcf1522906ff7cd99650671d36a788c0a2bbc2384bc2e7ad892a5c96666ca3: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:projection-evidence:document:e6f35099c1291158a9addc4a0a50e2118b08e3fe1ca78f72723bb1a6d5a1a541: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:projection-evidence:document:ce0ed99cf945cc8b381a90ec2e8c56de1f453e44d6725685938cfc26a2340234: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:projection-evidence:document:ff0b6d4eb95617660a96b052ea5b31ff4bf77acd4b885a5bdd7b69929c322267: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:projection-evidence:document:2d93a47596e17644c4bcea5aad8b625bba64903d0edc6b61dbfa0068bea2f7ac: [Eli Lilly director board source](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:projection-evidence:document:b459027c37cb8a9013662e0b07e857425a717e7a5b11f3bf5b6624cc9ced92ce: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:projection-evidence:document:f6326cbfa637699b5f7848e437804a64fd3cdc34df2c96b5f2d63de0f48345f1: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:projection-evidence:document:4a30c098a4a68e57eafaf7740a5eea207dee07f5a712687bb73d3957f6e80584: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:projection-evidence:document:c725f196ab40e8dfeaee09d14e12e788792f57b370209581b9e86f3b9ed80f75: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:projection-evidence:document:6ec4b33661a2eef359a5176343bdbc7a2d4a12e807fca67b8c0e2a9bf34df44c: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:projection-evidence:document:314fcb01d93646e1b1470c75eae79bb8f212dd4f354c1f72f50efcaa38b10ce8: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:projection-evidence:document:cffbb81b357bbe1614740a5ab14d015520e27f8590c7e92e5432b2a0c157f1d0: [Eli Lilly director board source](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:projection-evidence:document:334b0745cf84f53aa5f5d0fda5cba627b952c82477b730c40c7ec94e7bcd4531: LLY executive roster source. - alpha:projection-evidence:document:343df0b317f9d1e9978e9c350f18fdcabb40abb4a1f3f292c009e9d056e117e8: LLY executive roster source. - alpha:projection-evidence:document:ad62fa3d97af3c6c29f92650b3bf17c9b48f101547bef29f1c7202d5c666d08a: LLY executive roster source. - alpha:projection-evidence:document:299846c67451289b7468682bbf6e2271eca789ba4299cff991517fed7bff1a85: LLY executive roster source. - alpha:projection-evidence:document:571a3ae2a24c839ce4b2614fd38c75681b66eea7a926baa05d9cc5db6fe2d493: LLY executive roster source. - alpha:projection-evidence:document:dbbcca4ee29ed0233d90717206029da707483f3a5cca82b43f01a20819f85751: LLY executive roster source. - alpha:projection-evidence:document:c6bcf221e6c5cbef2ceb6c5c67bcafb23b4731dd21078a0614aae3ef80c18a8f: LLY executive roster source. - alpha:projection-evidence:document:0a31559e6fb655f082d3a87eec283e445815c879196b5283e6d208117d028701: LLY executive roster source. - alpha:projection-evidence:document:e269a8ea551874e338daad716989e73eb0cbc77af878c4f3736367df6c01275d: LLY executive roster source. - alpha:projection-evidence:document:55506d0bdb37d7ce7e46f5ffcaa79265a53b486bc4c3d7328df99ae54cd84a24: LLY executive roster source. - alpha:projection-evidence:document:02ae298c8e40d956c1c847839ceae7474cb8695ee35cf0f9ac23f9947e1ba5e9: LLY executive roster source. - alpha:projection-evidence:document:21a7ae2723c0aaf715aa0ad7c4393ff9d301fbcbddbe659020e438240086a473: LLY executive roster source. - alpha:projection-evidence:document:2c25184b065c1e34928156525bde08ae0108daa40dc0ef6144d183197f7cac39: LLY executive roster source. - alpha:projection-evidence:document:fef8c0c6217d0f2edc9141992ee09c46be42c3fb8dcfb525755c9a67e9302d6d: LLY executive roster source. - alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378: [Audit](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a: [S&P 500](https://www.slickcharts.com/sp500). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/eli-lilly-co) - [Public Markdown](https://registry.alpha.ac/companies/eli-lilly-co.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=jsonld) - MCP resource: `alpha://companies/eli-lilly-co` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T07:44:32.075818+00:00; recorded 2026-10-16T07:44:32.075818+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.